These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20877462)

  • 1. siRNA-based targeting of cyclin E overexpression inhibits breast cancer cell growth and suppresses tumor development in breast cancer mouse model.
    Liang Y; Gao H; Lin SY; Goss JA; Brunicardi FC; Li K
    PLoS One; 2010 Sep; 5(9):e12860. PubMed ID: 20877462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knocking down cyclin D1b inhibits breast cancer cell growth and suppresses tumor development in a breast cancer model.
    Wei M; Zhu L; Li Y; Chen W; Han B; Wang Z; He J; Yao H; Yang Z; Zhang Q; Liu B; Gu Q; Zhu Z; Shen K
    Cancer Sci; 2011 Aug; 102(8):1537-44. PubMed ID: 21521417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel interaction between HER2/neu and cyclin E in breast cancer.
    Mittendorf EA; Liu Y; Tucker SL; McKenzie T; Qiao N; Akli S; Biernacka A; Liu Y; Meijer L; Keyomarsi K; Hunt KK
    Oncogene; 2010 Jul; 29(27):3896-907. PubMed ID: 20453888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of RNA interference to target cyclin E-overexpressing hepatocellular carcinoma.
    Li K; Lin SY; Brunicardi FC; Seu P
    Cancer Res; 2003 Jul; 63(13):3593-7. PubMed ID: 12839946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
    Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
    Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Growth of breast cancer cells is inhibited in vitro by cyclin E-siRNA].
    He WS; Huang T; Ren JH
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):170-3. PubMed ID: 19615252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
    Luo HB; Li B; Yuan WG; Xu CR
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cyclin E overexpression on Smad3 activity in breast cancer cell lines.
    Cooley A; Zelivianski S; Jeruss JS
    Cell Cycle; 2010 Dec; 9(24):4900-7. PubMed ID: 21150326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol.
    Androic I; Krämer A; Yan R; Rödel F; Gätje R; Kaufmann M; Strebhardt K; Yuan J
    BMC Cancer; 2008 Dec; 8():391. PubMed ID: 19113992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noxin promotes proliferation of breast cancer cells via P38-ATF2 signaling pathway.
    Zhang X; Zhang Y; Fan C; Wang L; Liu Y; Li A; Jiang G; Zhou H; Cai L; Miao Y
    Tumour Biol; 2017 Jun; 39(6):1010428317705515. PubMed ID: 28618963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins.
    Chen CS; Lee CH; Hsieh CD; Ho CT; Pan MH; Huang CS; Tu SH; Wang YJ; Chen LC; Chang YJ; Wei PL; Yang YY; Wu CH; Ho YS
    Breast Cancer Res Treat; 2011 Jan; 125(1):73-87. PubMed ID: 20229177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.
    Lee YF; Miller LD; Chan XB; Black MA; Pang B; Ong CW; Salto-Tellez M; Liu ET; Desai KV
    Breast Cancer Res; 2012 May; 14(3):R85. PubMed ID: 22621393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis.
    Zhang L; Wang L; Dong D; Wang Z; Ji W; Yu M; Zhang F; Niu R; Zhou Y
    Cell Prolif; 2019 Jan; 52(1):e12527. PubMed ID: 30334298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells.
    Guo X; Hartley RS
    Cancer Res; 2006 Aug; 66(16):7948-56. PubMed ID: 16912169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cyclin E gene silencing on the proliferation of esophageal cancer cell lines, EC9706, Eca109 and KYSE30.
    Wang N; Li M; Zang WQ; Ma YY; Wang YY; Zhao GQ
    Mol Med Rep; 2013 Mar; 7(3):799-804. PubMed ID: 23338900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of human phosphatidylethanolamine-binding protein 4 sensitizes breast cancer cells to tumor necrosis factor-alpha-induced apoptosis and cell growth arrest.
    Wang X; Li N; Li H; Liu B; Qiu J; Chen T; Cao X
    Clin Cancer Res; 2005 Oct; 11(20):7545-53. PubMed ID: 16243830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of small interfering RNA targeting insulin-like growth factor-I receptor in ovarian cancer OVCAR3 cells.
    An Y; Cai Y; Guan Y; Cai L; Yang Y; Feng X; Zheng J
    Cancer Biother Radiopharm; 2010 Oct; 25(5):545-52. PubMed ID: 20950153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin e overexpression reduces infiltrative growth in breast cancer: yet another link between proliferation control and tumor invasion.
    Berglund P; Landberg G
    Cell Cycle; 2006 Mar; 5(6):606-9. PubMed ID: 16582601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin E overexpression obstructs infiltrative behavior in breast cancer: a novel role reflected in the growth pattern of medullary breast cancers.
    Berglund P; Stighall M; Jirström K; Borgquist S; Sjölander A; Hedenfalk I; Landberg G
    Cancer Res; 2005 Nov; 65(21):9727-34. PubMed ID: 16266993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.